[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-RNA":3,"homepage-market-summary":31,"stock-news-RNA":174},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"RNA","2026-10-08",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Atrium Therapeutics, Inc. Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.","391","San Diego, CA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},8.26,8.15,8.325,7.965,7.93,0.33,4.16,500328.904456,4969,8.2845,73.059998,7.63,1726012.8787138374,1,1589,{"status":32,"indices":33,"watchlist":76,"sectors":98,"benchmarks":153},"success",[34,41,48,56,63,70],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":14,"sparkline":40,"date":5},"SPX","S&P 500",7765.36,-36.41,-0.47,"0.0,10.5 2.3,12.4 4.6,14.2 6.9,16.0 9.3,11.5 11.6,10.8 13.9,4.8 16.2,4.8 18.5,7.9 20.8,8.0 23.2,6.0 25.5,9.1 27.8,9.8 30.1,10.8 32.4,10.0 34.7,7.0 37.1,4.4 39.4,2.0 41.7,2.9 44.0,4.8",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":14,"sparkline":47,"date":5},"NDX","NASDAQ 100",30725.81,-434.27,-1.39,"0.0,13.4 2.3,14.8 4.6,16.0 6.9,16.0 9.3,12.9 11.6,11.7 13.9,6.5 16.2,5.0 18.5,6.6 20.8,6.6 23.2,5.8 25.5,7.8 27.8,7.4 30.1,7.0 32.4,6.4 34.7,4.6 37.1,2.9 39.4,2.0 41.7,2.4 44.0,5.1",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":54,"sparkline":55,"date":5},"DJI","DOW JONES",51232,52,0.1,true,"0.0,2.0 2.3,3.3 4.6,6.0 6.9,11.3 9.3,8.7 11.6,9.5 13.9,6.4 16.2,8.0 18.5,10.9 20.8,12.3 23.2,8.2 25.5,11.2 27.8,12.3 30.1,16.0 32.4,15.8 34.7,13.7 37.1,13.0 39.4,10.8 41.7,13.7 44.0,13.3",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":14,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27193.34,-345.35,-1.25,"0.0,12.9 2.3,14.2 4.6,16.0 6.9,16.0 9.3,12.2 11.6,11.3 13.9,6.1 16.2,5.1 18.5,7.7 20.8,7.7 23.2,6.6 25.5,8.7 27.8,8.9 30.1,8.4 32.4,8.3 34.7,5.5 37.1,3.1 39.4,2.0 41.7,2.5 44.0,5.5",{"symbol":64,"name":65,"price":66,"change":67,"pct_change":68,"is_up":14,"sparkline":69,"date":5},"RUT","RUSSELL 2000",2775.7,-1.3,-0.05,"0.0,2.0 2.3,4.1 4.6,6.6 6.9,8.1 9.3,6.3 11.6,7.9 13.9,6.1 16.2,4.1 18.5,10.6 20.8,10.9 23.2,10.6 25.5,13.0 27.8,14.2 30.1,15.6 32.4,14.2 34.7,11.1 37.1,8.8 39.4,11.3 41.7,15.8 44.0,16.0",{"symbol":71,"name":72,"price":73,"change":21,"pct_change":74,"is_up":54,"sparkline":75,"date":5},"VIX","CBOE VIX",15.41,2.19,"0.0,9.5 2.3,4.4 4.6,4.0 6.9,2.0 9.3,11.1 11.6,13.6 13.9,13.4 16.2,16.0 18.5,12.1 20.8,10.2 23.2,13.4 25.5,8.6 27.8,8.7 30.1,7.5 32.4,7.3 34.7,11.6 37.1,10.8 39.4,12.8 41.7,12.5 44.0,11.2",[77,84,91],{"symbol":78,"name":79,"price":80,"change":81,"pct_change":82,"is_up":14,"sparkline":83,"date":5},"NVDA","NVIDIA Corp",230.48,-6.99,-2.94,"0.0,16.0 7.3,12.8 14.7,8.8 22.0,2.4 29.3,2.0 36.7,4.3 44.0,13.3",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":54,"sparkline":90,"date":5},"AAPL","Apple Inc",340.43,3.76,1.12,"0.0,12.3 7.3,16.0 14.7,11.3 22.0,12.4 29.3,11.4 36.7,7.2 44.0,2.0",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":14,"sparkline":97,"date":5},"TSLA","Tesla Inc",375,-2.81,-0.74,"0.0,15.6 7.3,16.0 14.7,7.3 22.0,3.0 29.3,2.0 36.7,3.5 44.0,5.0",[99,104,109,114,119,124,129,133,138,143,148],{"name":100,"etf":101,"change":102,"price":103,"is_up":14},"Technology","XLK",-1.79,197.78,{"name":105,"etf":106,"change":107,"price":108,"is_up":54},"Financials","XLF",0.89,54.23,{"name":110,"etf":111,"change":112,"price":113,"is_up":14},"Healthcare","XLV",-0.39,168.16,{"name":115,"etf":116,"change":117,"price":118,"is_up":54},"Consumer Cycl","XLY",0.31,111.7,{"name":120,"etf":121,"change":122,"price":123,"is_up":54},"Consumer Staples","XLP",2.11,83.42,{"name":125,"etf":126,"change":127,"price":128,"is_up":54},"Energy","XLE",2.97,65.24,{"name":130,"etf":131,"change":21,"price":132,"is_up":54},"Industrials","XLI",168.4,{"name":134,"etf":135,"change":136,"price":137,"is_up":54},"Materials","XLB",0.59,49.27,{"name":139,"etf":140,"change":141,"price":142,"is_up":54},"Real Estate","XLRE",0.69,40.85,{"name":144,"etf":145,"change":146,"price":147,"is_up":14},"Utilities","XLU",-0.19,41.07,{"name":149,"etf":150,"change":151,"price":152,"is_up":54},"Comm Services","XLC",0.73,112.07,[154,159,164,169],{"ticker":155,"name":156,"price":157,"change":158,"is_up":14},"SPY","SPDR S&P 500 ETF",773.97,-0.42,{"ticker":160,"name":161,"price":162,"change":163,"is_up":14},"QQQ","Invesco QQQ Trust",747.58,-1.34,{"ticker":165,"name":166,"price":167,"change":168,"is_up":54},"DIA","SPDR Dow Jones ETF",511.65,0.12,{"ticker":170,"name":171,"price":172,"change":173,"is_up":14},"IWM","iShares Russell 2000",277.63,-0.03,{"ticker":4,"count":175,"articles":176},20,[177,183,189,195,201,207,213,219,225,231,237,242,248,254,260,265,271,276,281,286],{"title":178,"link":179,"pubDate":180,"description":181,"source":182},"Atrium Therapeutics Announces $50 Million Private Placement - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipAFBVV95cUxOUnJmSVZyY3Y2X3FjeF9KYmxjVXRNelcweGlKNXBtUWN3dTByWkRtb2RJZFNPUVBXXzFNRm9MeU1kWUhoUllNX1VIVVdQQlAtSHRQRjhhamxySFo3a3NGMWJ6ZjBRTTZsOGQ3Nnp1dUpDSUdjdmhndE5qVTVkeE44aEIzTDJ6MDNXWTlhYWRuUzNBcFVMRTM3UUl6Ui1jSVpRWGtXVQ?oc=5","Thu, 08 Oct 2026 10:30:00 GMT","Atrium Therapeutics Announces $50 Million Private Placement Stock Titan","Stock Titan",{"title":184,"link":185,"pubDate":186,"description":187,"source":188},"Gene Silencing Biotech ADARx Makes Some Noise With $535M Stock Market Debut - MedCity News","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimgFBVV95cUxQUDA5VWxJbUx3bktCWHBid2RfSmtaS2hObUJHNW0wNXdQWkFzVjduQ0lKZnkyazBXZFJQRjJWVnM3OHZZNExhQWNQNUFEbG1xNnNhUHhiSFpqTDg4ZTNjbEc0b0xlaTJCSjAzc2FLdUV6OWdwXzdlS2xKdE15UWtGWGQ2S3dKczlYR2F6WllnU0R4enBFYWlSYmxn?oc=5","Fri, 25 Sep 2026 07:00:00 GMT","Gene Silencing Biotech ADARx Makes Some Noise With $535M Stock Market Debut MedCity News","MedCity News",{"title":190,"link":191,"pubDate":192,"description":193,"source":194},"Novartis wagers almost $8B on a Chinese biotech’s RNA drugs - BioPharma Dive","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMikAFBVV95cUxORWhYRVZYSWVlcnZUamdnVVVRZkktSE9YMEpwSnY1cGNRcTl6MkxnMk9aTzRUOUN6VDhjVWdVTVE0WmE5QlQzWThBRkF1NDBhYi1QNmJ3Q2FOQ2NtRzRTdV8tWFQ5RDZUVnFNYUdPVm9SR1NPdXBXQ0wzTXY4eDFDb3dGNGVpa2lHbVN4am5xNkE?oc=5","Sat, 03 Oct 2026 04:11:38 GMT","Novartis wagers almost $8B on a Chinese biotech’s RNA drugs BioPharma Dive","BioPharma Dive",{"title":196,"link":197,"pubDate":198,"description":199,"source":200},"Wave Life Sciences Aligns With FDA on Registrational Path for RNA Editing Therapy WVE-006 in AATD - BioPharm International","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi1wFBVV95cUxOQU5fRkhBVmtWX0lUTmFfVnNRRkNXc2I2NE5LSGZDTUYtSzRGV0E2QndGN09rRnpHVUVhZXJLV0MtaDBsMTROeUF4UWJ6dEVjZmZwdUVTNjBBRmFCOGhIZld6MWw5STAyTnlncTB6NUYzOTRlNkJxZ090RXVWdklkS2VTeTl5ajdDQ0Q5bG9vb2dodlhETWQyc1ZpRDNjZlJUUEltUXQtS2xPZjh5eHJpV1l0RFhEM01fY1JKemhZdlhUdzNQOVhzeF9IOHAwYzk3QU1SRVJKTQ?oc=5","Thu, 01 Oct 2026 20:16:23 GMT","Wave Life Sciences Aligns With FDA on Registrational Path for RNA Editing Therapy WVE-006 in AATD BioPharm International","BioPharm International",{"title":202,"link":203,"pubDate":204,"description":205,"source":206},"4 RNA Therapeutics Stocks Leading the Next Wave of Innovation - Zacks Investment Research","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipAFBVV95cUxNQ2d4QlY5c3BOQVhfU2ItcGxOakpSNjQ3ZE5ocnBFcnE0WHpQeTJNZkM4WkJOS2N2YlJWVEtCTVR1ckJ4UXJLVVJ5cTFaVUFVQURVdExNczRpcWx4VEMxRFBjenpNaUJWNE5Uc0YtcWFpX2VvdzVRaEo0TG0zSW92dE5ydHV4SjdYZW9scjBoQlJ3d2MzUmotdzkzNTdaM2t5UlIxbw?oc=5","Mon, 28 Sep 2026 14:09:26 GMT","4 RNA Therapeutics Stocks Leading the Next Wave of Innovation Zacks Investment Research","Zacks Investment Research",{"title":208,"link":209,"pubDate":210,"description":211,"source":212},"Patients Remain Undetectable 96 Weeks After Stopping Bulevirtide - AJMC","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitAFBVV95cUxNaEdsUjZFcVl4dVg0YmNoLV8yY043LUNoeGpXNnN2eklkaVBhLTg5eGt3ZmQzcnNPSHpEQ2dZU1JxcEQ3RDVrbEE2LUh0SDQ2WFhiX19GWEtKMERTLU56aktNY2FkNGN2UUpFSnNGZFd5cnV1RHVHUml3WXE5ajkySHNKZXhwMVVldXVEUHBFV0JibGxzdEdSc2hDTEN6cFdpellGRUFjdDh1cUVkVk1GZWhKNm4?oc=5","Tue, 29 Sep 2026 19:21:53 GMT","Patients Remain Undetectable 96 Weeks After Stopping Bulevirtide AJMC","AJMC",{"title":214,"link":215,"pubDate":216,"description":217,"source":218},"Novartis Strengthens RNA Therapeutics Pipeline With $7.8B Abogen Deal - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqwFBVV95cUxPZXN5NG01UmY1TEYybUlnTUZNdVhmOUtieG55eFozT0l6TzBjTkxRQmNPeWlsSmRCMHBwMGtuTXNPQWZUbWFlRGhjdHdkOTZPeDNuOG4tdE5KdUlmTjBrb1JQMGN4eEUwdFhycTdNVE5GWFZyWlN1MkdGY1QwVHpqOVRmT0ZBTVZEWlp6ZXpGNGtRSllFOTJRclh0amFaSjJ5U19FWjRnSmRTbXc?oc=5","Mon, 05 Oct 2026 15:21:00 GMT","Novartis Strengthens RNA Therapeutics Pipeline With $7.8B Abogen Deal Yahoo Finance","Yahoo Finance",{"title":220,"link":221,"pubDate":222,"description":223,"source":224},"ADARx’s $446m IPO signals investor appetite for next-gen RNA therapeutics - BioXconomy","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirwFBVV95cUxOM1ZITW1vd2l5dXM0cERfYjFINGQ5TzZlTWNQRmwwWUhidkFrLW9aNkJrVE93bXd2SnR5eEhpR2xMc1JNa0N3a3hYY0FGZzBGUzNvelZhVmRMaUV5WG5wYTFqTmY4N1lxSFpkaUM2ank3SDFHcFhwTFVTUW1DZ3pGTU0wbzdSLUZHMTF2bTZ1eXpSQnFSclRkMnBGRkV5M083QTZyejVYTFpYMzEzYWFz?oc=5","Tue, 29 Sep 2026 07:00:00 GMT","ADARx’s $446m IPO signals investor appetite for next-gen RNA therapeutics BioXconomy","BioXconomy",{"title":226,"link":227,"pubDate":228,"description":229,"source":230},"Technical Reactions to RNA Trends in Macro Strategies - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMizAFBVV95cUxOLXVZQV9hZkxySEFzc2JJc2RvTVJYUGdsV3l6OWZnaFdnd0x0RGU0RjV5TnBxQWozUXFVemdCN2owMG5DbU5GWjNMTmtOTnZiTm1KMVlRR1lQUGd2dXRna293dlFSZV9JNVFZczlNLWFhZWZkLWZaVTNrYmtiNUlVb1U5b0tsb1FoNmhHUUtUeFJ6WExDM3gtR1VvNl9MWWpvUURIN0ZEWDlHOVBNdWE3NjZIN2xrNjN4NzhPdUVKakNyZW1HWVpqVzY3VWc?oc=5","Sat, 03 Oct 2026 17:24:02 GMT","Technical Reactions to RNA Trends in Macro Strategies Stock Traders Daily","Stock Traders Daily",{"title":232,"link":233,"pubDate":234,"description":235,"source":236},"Camp4 Therapeutics (Nasdaq:CAMP) - Stock Analysis - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMijwFBVV95cUxNeXRnMFBDRGNheWRRa2hSWlU5dUVyMnlUeWVQTEhvd3VORmVJRjN6OGFCUnVTX2ZNNFpXYXA4LUlmZDU4MzBwT3lPV1B5NzdtOUZUSGh2bkkxdHg0dmh4RXBfZEcydHkzWHVGeWJOVGppYkVzcE1yU2UtR21PMjJZSkNJRHNzUTUydTBvMnA2OA?oc=5","Mon, 28 Sep 2026 07:00:00 GMT","Camp4 Therapeutics (Nasdaq:CAMP) - Stock Analysis Simply Wall Street","Simply Wall Street",{"title":238,"link":239,"pubDate":180,"description":240,"source":241},"Atrium Therapeutics Announces $50 Million Private Placement - themountaineer.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi1gFBVV95cUxObGhtNndWQ1NhRkw2YkFfMXNhUTR4ZlE3QXFwSDhINU9UWnlhVG0wb1N5dkg0LXMtYkFIdkRNbnJQQ1VaWTB6YlZFVEN2M195NnJ2dVFuOG9QVHFKZFppNkl0OUlNSE01SHlMY1AxbFV6aVpPSnlJbGJhc3dJQS1CNldybHRCRldtTjF2Z0JJZ2UwUllSeVRQdHNuRWdVSlpCUldiVWlQYk1nRDVqVXVBR1dQZHlneUlkemw1Ny1BelpmZm1oOTNhdjVaX19ua0FGbEpJN0FB?oc=5","Atrium Therapeutics Announces $50 Million Private Placement themountaineer.com","themountaineer.com",{"title":243,"link":244,"pubDate":245,"description":246,"source":247},"Atrium Therapeutics Secures $50 Million Private Placement to Advance RNA-Based Cardiology Pipeline - citybiz","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi0gFBVV95cUxPazJMM2dSaXpscHdFV1ZtT0hnUW5OUXRmNXFDQUNIYkY1cTdoVEZ1cFpjbFJ4QjNNSTk4bEZvYzFzMGJfLUNMN0tYNXFOTHdxeXNHNnd0bFFFclZxQ2V5Q3BtQXExNDE3OXBvY2JQbzI3OE5LMUhCRVBSTm9yX3o1UV9sVXhaZEdrQ24wcGk0SmFsZXdqbTN5SVlwRGNxTmhYeEFSVEMtbGNBZldSUHRyNWRvbG1uYkV5Y2ZSSGU4RWwtNk9FaXRmLUZvaTVreVF2WFE?oc=5","Thu, 08 Oct 2026 13:47:08 GMT","Atrium Therapeutics Secures $50 Million Private Placement to Advance RNA-Based Cardiology Pipeline citybiz","citybiz",{"title":249,"link":250,"pubDate":251,"description":252,"source":253},"PacBio Deepens AI Drug-Discovery Push With TychoBio Deal — PACB Stock Takes A Breather After 103% Rally - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi8wFBVV95cUxPTXN2UzMyUDBDa3ozaUxoM25TdmNudV9aUEZaeEh5MWlUbTN3d3k2cU9MbmhtSTBpemZUN0cwSDItM2dYV0JfekhCYzkzSGt2TnFwUEx1THhCaUgtVWJKYVQxX2d1aEZzX0V4RFNnUEF0aGN2bm45QXZUdEEtYmZhSWtrSTZQeGJacXYxU0N5OGVXZVNrazZoeVhnMVFGREVNVkxiUW9YcENPbmFNbWtIdy1iN05FQVFITkc1WXpFM1FxT3dpN0x6eVBlRjBJQU9hQThpdzg5UzRHVDFYUUxvaXpIclU3eXNVa2NMT3pyanNLTkE?oc=5","Tue, 06 Oct 2026 15:23:46 GMT","PacBio Deepens AI Drug-Discovery Push With TychoBio Deal — PACB Stock Takes A Breather After 103% Rally TradingView","TradingView",{"title":255,"link":256,"pubDate":257,"description":258,"source":259},"Avidity Biosciences misses HARBOR endpoint: analysts target RNA stock at USD 63.75 - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi1wFBVV95cUxQaVZQOHdQZ0lHMFF5WnZ1WGxiaWZKbGgzcS01VmVfUXZCam9YbDlVM3BsZ09OUFZZalVQM08wMzNlRWFTajdaSEZlVEZjdFQxRkFLb0V2Q21TLWd5bmdtWFpCS0QycUJVNUluOEU4cGRsNTZ2b3JldTBOQnNJLXl5OVBva1ZhSlNSLXRwMTRnbzNLQzJ6eE9sc2c4M1NzblFQSWs2bDdhRmtBdnRIdlNCNktaZmJQZHV4TU5xSGM1bkxINUJYYy1WYnc3ekdGOHg4TXJqbVJ2bw?oc=5","Tue, 06 Oct 2026 09:20:02 GMT","Avidity Biosciences misses HARBOR endpoint: analysts target RNA stock at USD 63.75 AD HOC NEWS","AD HOC NEWS",{"title":261,"link":262,"pubDate":263,"description":264,"source":182},"Over 10,000 samples will supply data for a planned AI effort to design rare-disease RNA treatments. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitwFBVV95cUxOY3FRMlFwdGVsSV9qVDI0SDhOaUJfbThmUmE2RmNidzJPN1F4c0JBTjNKQ1lsTjRLM3diVmJjbW4xcW9BZWs4Y1FLRHg1VFZJNXlKZ09HZ1hCWFRGaEQ2cFdqMkRqWHBWekJ4U2Y5ZGFTMUJJeGRDMi0xdGRDRDRHSi1ueHFrM2tkWDM2WVpsSWkwdTlLd2dUUURFQ1lBdUh5aUwzUjRmNXNrMnF1ZmdySGJnc0ljLTg?oc=5","Tue, 06 Oct 2026 13:05:00 GMT","Over 10,000 samples will supply data for a planned AI effort to design rare-disease RNA treatments. Stock Titan",{"title":266,"link":267,"pubDate":268,"description":269,"source":270},"Wave Life Sciences, Inc. (WVE) Stock Price, News, Quote & History - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiUEFVX3lxTE5KeFo5WUxJN2dBMWN4Yjd5NER3RS1Ga240TWRyQllGOGF5ejNlc1Q2bVByWlliS2hDaVFMZW5ZamNWdVdERkkxLVB3bGhJbl85?oc=5","Thu, 08 Oct 2026 02:35:46 GMT","Wave Life Sciences, Inc. (WVE) Stock Price, News, Quote & History Yahoo! Finance Canada","Yahoo! Finance Canada",{"title":272,"link":273,"pubDate":274,"description":275,"source":206},"Novartis Strengthens RNA Therapeutics Pipeline With $7.8B Abogen Deal - Zacks Investment Research","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirAFBVV95cUxQZUMySXJ6QURvbWNWNzlpVUhTV0xadzVMYjUyaEtCUmtWVkZXVXpxdzN2cmF4MUttQlVjWWlwTE9HWEZJVkw1SDF3ZzhZSGl1eE9FeG1rVEZQRVE2UmdlbGR1bFptTUQtQUlhRkc2MFk5ZXhZclhjdmJ4V0xQN3FWSkQtTWRvUExLRUFsX05xaEdiUUNkbVJvNVc2T1ZuTXVsU1luSXJ3RFRSYmFa?oc=5","Mon, 05 Oct 2026 15:33:08 GMT","Novartis Strengthens RNA Therapeutics Pipeline With $7.8B Abogen Deal Zacks Investment Research",{"title":277,"link":278,"pubDate":279,"description":280,"source":236},"How Investors Are Reacting To Recursion Pharmaceuticals (RXRX) RNA Model Licensing Deal - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Fri, 25 Sep 2026 22:41:45 GMT","How Investors Are Reacting To Recursion Pharmaceuticals (RXRX) RNA Model Licensing Deal Simply Wall Street",{"title":282,"link":283,"pubDate":284,"description":285,"source":270},"Alnylam Pharmaceuticals, Inc. (ALNY) Stock Price, News, Quote & History - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiUkFVX3lxTE9Uang3NWtWZ1RfNF8zdlkzN0NtWHV0MzY5U2R0NFIwd08zdm5FNnNabXF3OWxIWFMxVHZJS3hDWEQ1ZkFsdzU5WktRSTFvLXExLWc?oc=5","Wed, 07 Oct 2026 06:24:15 GMT","Alnylam Pharmaceuticals, Inc. (ALNY) Stock Price, News, Quote & History Yahoo! Finance Canada",{"title":287,"link":288,"pubDate":289,"description":290,"source":182},"FDA supports a one-year data check for possible faster approval of Wave's treatment. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuwFBVV95cUxNQnhrenlMN3ZuTzlNUFRFUURrLTI5RGlPWEIxS1p3eWpVUEdjbnJGdWwwYkM5MU5Idk5tSGYxeUJpWEJoMnNpSzBQaUE3a3lLUHN4LUExMjh3UVVKYTRzQVoyVHBxbW9ERlAxSlZCN1FNcFJVUU05dzdtQ1lBeHF3bkZOd29kZFpiWGtIR0cwUy1WTWZPdTYtYWRXcTl6RVF1Yi1rWllCQ1c0MjhZcFVnQjh1SllONzlVQ2ow?oc=5","Thu, 01 Oct 2026 11:30:00 GMT","FDA supports a one-year data check for possible faster approval of Wave's treatment. Stock Titan"]